Issue 123 • October 2022 Nanorobots: small solutions to big delivery problems Brazil: an untapped market for big pharma manufacturing Foreign investments amplify the nucleic acid therapeutics field In association with Exploring the promise of billion-dollar KRAS drugs KRAS mutations are one of the most prevalent drivers of cancer, yet they were long considered ‘undruggable’; a new wave of drugs is changing that In association with Issue 122 Brought to you by 09/21/2022 13:15:06